Authors:
BJORKSTRAND B
LJUNGMAN P
SVENSSON H
HERMANS I
ALEGRE A
APPERLEY I
BLADE I
CARLSON K
CAVO M
FERRANT A
GOLDSTONE AH
DELAURENZI A
MAJOLINO I
MARCUS R
PRENTICE HG
REMES K
SAMSON D
SUREDA A
VERDONCK LF
VOLIN L
GAHRTON G
Citation: B. Bjorkstrand et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION IS ASSOCIATED WITH BETTER SURVIVAL THAN ALLOGENEIC BMT IN MULTIPLE-MYELOMA - RESULTS OF A RETROSPECTIVE CASE-MATCHED STUDY IN 378 PATIENTS, Experimental hematology, 24(9), 1996, pp. 657-657
Authors:
SAMSON D
VOLIN L
SCHANZ U
BOSI A
GAHRTON G
Citation: D. Samson et al., FEASIBILITY AND TOXICITY OF INTERFERON MAINTENANCE THERAPY AFTER ALLOGENEIC BMT FOR MULTIPLE-MYELOMA - A PILOT-STUDY OF THE EBMT, Bone marrow transplantation, 17(5), 1996, pp. 759-762
Authors:
SIMONSSON B
OBERG G
BJOREMAN M
BJORKHOLM M
CARNESKOG J
GAHRTON G
HAST R
KARL H
LANNGNIELSEN J
LOFVENBERG E
MALM C
TURESSON I
UDEN AM
VILEN L
WEISBJERRUM O
Citation: B. Simonsson et al., INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CML, Bone marrow transplantation, 17, 1996, pp. 63-64
Authors:
FRASSONI F
LABOPIN M
GLUCKMAN E
PRENTICE HG
VERNANT JP
ZWAAN F
GRANENA A
GAHRTON G
DEWITTE T
GRATWOHL A
REIFFERS J
GORIN NC
Citation: F. Frassoni et al., RESULTS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE-LEUKEMIA HAVE IMPROVED IN EUROPE WITH TIME - A REPORT OF THE ACUTE-LEUKEMIA WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION (EBMT), Bone marrow transplantation, 17(1), 1996, pp. 13-18
Authors:
GRATWOHL A
HERMANS J
VONBIEZEN A
ARCESE W
DEBUSSCHER L
ERNST P
FERRANT A
FRASSONI F
GAHRTON G
IRIONDO A
KOLB HJ
LINK H
NIEDERWIESER D
RUUTU T
SCHATTENBERG A
SCHMITZ N
SIEGERT W
TORRESGOMEZ A
VERNANT JP
ZWAAN FE
APPERLEY J
Citation: A. Gratwohl et al., SPLENIC IRRADIATION BEFORE BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA, British Journal of Haematology, 95(3), 1996, pp. 494-500
Authors:
MERUP M
SPASOKOUKOTSKAJA T
EINHORN S
SMITH CI
GAHRTON G
JULIUSSON G
Citation: M. Merup et al., BCL-2 REARRANGEMENTS WITH BREAKPOINTS IN BOTH VCR AND MBR IN NON-HODGKINS-LYMPHOMAS AND CHRONIC LYMPHOCYTIC-LEUKEMIA, British Journal of Haematology, 92(3), 1996, pp. 647-652
Authors:
GRATWOHL A
HERMANS J
BALDOMERO H
TICHELLI A
GOLDMAN JM
GAHRTON G
Citation: A. Gratwohl et al., INDICATIONS FOR HEMATOPOIETIC PRECURSOR CELL TRANSPLANTS IN EUROPE, British Journal of Haematology, 92(1), 1996, pp. 35-43
Authors:
BJORKSTRAND B
LJUNGMAN P
SVENSSON H
HERMANS J
ALEGRE A
APPERLEY J
BLADE J
CARLSON K
CAVO M
FERRANT A
GOLDSTONE AH
DELAURENZI A
MAJOLINO I
MARCUS R
PRENTICE HG
REMES K
SAMSON D
SUREDA A
VERDONCK LF
VOLIN L
GAHRTON G
Citation: B. Bjorkstrand et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION VERSUS AUTOLOGOUS STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - A RETROSPECTIVE CASE-MATCHED STUDYFROM THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION, Blood, 88(12), 1996, pp. 4711-4718
Authors:
WU X
MERUP M
JULIUSSON G
JANSSON M
STELLAN B
GRANDER D
ZABAROVSKY E
LIU Y
SPASKOUKOTSKAJA T
GAHRTON G
EINHORN S
Citation: X. Wu et al., CHARACTERIZATION OF THE HAIRY-CELL LEUKEMIA-ASSOCIATED BREAKPOINT AT 5Q13.3 IN A PATIENT WITH A CONSTITUTIONAL INVERSION, Blood, 88(10), 1996, pp. 252-252
Authors:
CORCORAN M
LIU Y
MULLENBACH R
IBBOTSON R
RASOOL O
IYENGAR A
GRANDER D
CHAPMAN R
YANKOVSKY N
WU X
MERUP M
JULIUSSON G
GAHRTON G
BRODYANSKY V
BUYS C
ZABAROVSKY E
OSCIER D
EINHORN S
Citation: M. Corcoran et al., CHARACTERIZATION OF THE MINIMAL AREA OF HOMOZYGOUS 13Q14.3 DELETION IN B-CLL AND ISOLATION OF CANDIDATE TUMOR-SUPPRESSOR GENES, Blood, 88(10), 1996, pp. 1419-1419
Authors:
MICHALLET M
ARCHIMBAUD E
BANDINI G
ROWLINGS PA
DEEG HJ
GAHRTON G
MONTSERRAT E
ROZMAN C
GRATWOHL A
GALE RP
Citation: M. Michallet et al., HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION IN YOUNGER PATIENTSWITH CHRONIC LYMPHOCYTIC-LEUKEMIA, Annals of internal medicine, 124(3), 1996, pp. 311-315
Authors:
GAHRTON G
TURA S
LJUNGMAN P
BLADE J
CAVO M
DELAURENZI A
FACON T
GRATWOHL A
MICHALLET M
NIKOSKELAINEN J
PEARCE R
REIFFERS J
SAMSON D
SCHATTENBERG A
VERDONCK L
VERNANT JP
VOLIN L
Citation: G. Gahrton et al., AN UPDATE OF PROGNOSTIC FACTORS FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MULTIPLE-MYELOMA USING MATCHED SIBLING DONORS, Stem cells, 13, 1995, pp. 122-125
Authors:
BJORKSTRAND B
LJUNGMAN P
BIRD JM
SAMSON D
BRANDT L
ALEGRE A
AUZANNEAU G
BLADE J
BRUNET S
CARLSON K
CAVO M
FERRANT A
GRAVETT P
DELAURENZI A
PRENTICE HG
PROCTOR S
REMES K
TROUSSARD X
VERDONCK LF
WILLIAMS C
GAHRTON G
Citation: B. Bjorkstrand et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - RESULTS OFTHE EUROPEAN GROUP FOR BONE-MARROW TRANSPLANTATION, Stem cells, 13, 1995, pp. 140-146
Authors:
LI KJ
DILBER MS
ABEDI MR
BJORKSTRAND B
SMITH CIE
GAROFF H
GAHRTON G
XANTHOPOULOS KG
Citation: Kj. Li et al., RETROVIRAL-MEDIATED GENE-TRANSFER INTO HUMAN BONE-MARROW STROMAL CELLS - STUDIES OF EFFICIENCY AND IN-VIVO SURVIVAL IN SCID MICE, European journal of haematology, 55(5), 1995, pp. 302-306
Authors:
BJORKHOLM M
LILIEMARK J
GAHRTON G
GRIMFORS G
GRUBER A
HAST R
JULIUSSON G
JARNMARK M
KILLANDER A
KIMBY E
LERNER R
LJUNGMAN P
LONNQVIST B
PALMBLAD J
PAUL C
PETTERSON C
SIMONSSON B
STALFELT AM
STENKE L
SUNDSTROM C
TIDEFELT U
UDEN AM
OBERG G
OST A
Citation: M. Bjorkholm et al., MITOXANTRONE, ETOPOSIDE AND ARA-C VS DOXORUBICIN-DNA, ARA-C, THIOGUANINE, VINCRISTINE AND PREDNISOLONE IN THE TREATMENT OF PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA - A RANDOMIZED COMPARISON, European journal of haematology, 55(1), 1995, pp. 19-23
Authors:
GAHRTON G
TURA S
LJUNGMAN P
BLADE J
BRANDT L
CAVO M
FACON T
GRATWOHL A
HAGENBEEK A
JACOBS P
DELAURENZI A
VANLINT M
MICHALLET M
NIKOSKELAINEN J
REIFFERS J
SAMSON D
VERDONCK L
DEWITTE T
VOLIN L
Citation: G. Gahrton et al., PROGNOSTIC FACTORS IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MULTIPLE-MYELOMA, Journal of clinical oncology, 13(6), 1995, pp. 1312-1322
Authors:
LIU Y
GAHRTON G
GRANDER D
JULIUSSON G
SODERHALL S
EINHORN S
Citation: Y. Liu et al., EVIDENCE FOR A NEW TUMOR-SUPPRESSOR GENE AT 13Q14 IN CHRONIC LYMPHOCYTIC-LEUKEMIA, Cytogenetics and cell genetics, 70(1-2), 1995, pp. 19-19
Authors:
RINGDEN O
REMBERGER M
PERSSON U
LJUNGMAN P
ALDENER A
ANDSTROM E
ASCHAN J
BOLME P
DAHLLOF G
DALIANIS T
GAHRTON G
HAGGLUND H
LONNQVIST B
OLERUP O
SHANWELL A
SPARRELID E
WINIARSKI J
MOLLER E
OBERG M
Citation: O. Ringden et al., SIMILAR INCIDENCE OF GRAFT-VERSUS-HOST DISEASE USING HLA-A, HLA-B ANDHLA-DR IDENTICAL UNRELATED BONE-MARROW DONORS AS WITH HLA-IDENTICAL SIBLINGS, Bone marrow transplantation, 15(4), 1995, pp. 619-625
Authors:
BJORKSTRAND B
LJUNGMAN P
BIRD JM
SAMSON D
GAHRTON G
Citation: B. Bjorkstrand et al., DOUBLE HIGH-DOSE CHEMORADIOTHERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION CAN INDUCE MOLECULAR REMISSIONS IN MULTIPLE-MYELOMA, Bone marrow transplantation, 15(3), 1995, pp. 367-371
Authors:
LIU Y
HERMANSON M
GRANDER D
MERUP M
WU XS
HEYMAN M
RASOOL O
JULIUSSON G
GAHRTON G
DETLOFSSON R
NIKIFOROVA N
BUYS C
SODERHALL S
YANKOVSKY N
ZABAROVSKY E
EINHORN S
Citation: Y. Liu et al., 13Q DELETIONS IN LYMPHOID MALIGNANCIES, Blood, 86(5), 1995, pp. 1911-1915